| 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association SM Greenberg, WC Ziai, C Cordonnier, D Dowlatshahi, B Francis, ... Stroke 53 (7), e282-e361, 2022 | 960 | 2022 |
| Post-stroke dysphagia: a review and design considerations for future trials DL Cohen, C Roffe, J Beavan, B Blackett, CA Fairfield, S Hamdy, ... International Journal of Stroke 11 (4), 399-411, 2016 | 524 | 2016 |
| Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial N Sprigg, K Flaherty, JP Appleton, RAS Salman, D Bereczki, M Beridze, ... The Lancet 391 (10135), 2107-2115, 2018 | 486 | 2018 |
| Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised … ENOS Trial Investigators The Lancet 385 (9968), 617-628, 2015 | 350 | 2015 |
| Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2 … D Wilson, G Ambler, C Shakeshaft, MM Brown, A Charidimou, ... The Lancet Neurology 17 (6), 539-547, 2018 | 261 | 2018 |
| The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial L Ma, X Hu, L Song, X Chen, M Ouyang, L Billot, Q Li, A Malavera, X Li, ... The Lancet 402 (10395), 27-40, 2023 | 206 | 2023 |
| Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... The Lancet 393 (10191), 2613-2623, 2019 | 202 | 2019 |
| RECAST (remote ischemic conditioning after stroke trial) a pilot randomized placebo controlled phase II trial in acute ischemic stroke TJ England, A Hedstrom, S O’Sullivan, R Donnelly, DA Barrett, S Sarmad, ... Stroke 48 (5), 1412-1415, 2017 | 194 | 2017 |
| Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a … PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ... The Lancet 391 (10123), 850-859, 2018 | 192 | 2018 |
| Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies D Wilson, G Ambler, KJ Lee, JS Lim, M Shiozawa, M Koga, L Li, ... The Lancet Neurology 18 (7), 653-665, 2019 | 190 | 2019 |
| Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial PM Bath, P Scutt, CS Anderson, JP Appleton, E Berge, L Cala, M Dixon, ... The Lancet 393 (10175), 1009-1020, 2019 | 190 | 2019 |
| Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke … S Ankolekar, M Fuller, I Cross, C Renton, P Cox, N Sprigg, ... Stroke 44 (11), 3120-3128, 2013 | 182 | 2013 |
| Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data G Thomalla, F Boutitie, H Ma, M Koga, P Ringleb, LH Schwamm, O Wu, ... The Lancet 396 (10262), 1574-1584, 2020 | 178 | 2020 |
| Hypercholesterolaemia and vascular dementia JP Appleton, P Scutt, N Sprigg, PM Bath Clinical Science 131 (14), 1561-1578, 2017 | 166 | 2017 |
| Sex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) LJ Gray, N Sprigg, PMW Bath, G Boysen, PP De Deyn, D Leys, D O’Neill, ... Stroke 38 (11), 2960-2964, 2007 | 166 | 2007 |
| Outcome of intracerebral hemorrhage associated with different oral anticoagulants D Wilson, DJ Seiffge, C Traenka, G Basir, JC Purrucker, T Rizos, ... Neurology 88 (18), 1693-1700, 2017 | 165 | 2017 |
| Granulocyte-Colony–Stimulating Factor Mobilizes Bone Marrow Stem Cells in Patients With Subacute Ischemic Stroke: The Stem Cell Trial of Recovery EnhanceMent After … N Sprigg, PM Bath, L Zhao, MR Willmot, LJ Gray, MF Walker, MS Dennis, ... Stroke 37 (12), 2979-2983, 2006 | 165 | 2006 |
| Stroke in women—from evidence to inequalities C Cordonnier, N Sprigg, EC Sandset, A Pavlovic, KS Sunnerhagen, ... Nature Reviews Neurology 13 (9), 521-532, 2017 | 164 | 2017 |
| Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2) KW Muir, D Bulters, M Willmot, N Sprigg, A Dixit, N Ward, P Tyrrell, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (4), 396-401, 2020 | 145 | 2020 |
| Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke PMW Bath, N Sprigg, T England Cochrane Database of Systematic Reviews, 2013 | 130 | 2013 |